Peptide directoryBrain, hypothalamus & pituitary

Alpha-neoendorphin

A ten-residue kappa opioid from the front of prodynorphin.

Related medicinesNalfurafineDifelikefalin

Where it comes from

Made in
Hypothalamus, striatum and pituitary, with the dynorphins
Sent out by
With the dynorphins
Acts on
  • Kappa receptors

What it does

  • A potent opiate agonist, as all the prodynorphin peptides are, and the first of them to be isolated 1
  • Cut from prodynorphin ahead of dynorphin A, so a tissue rich in it is using a different set of processing enzymes 3
  • Trimmed by one residue to beta-neoendorphin, which is a little weaker 2

In medicine

  • No medicine copies it, and it is not measured outside research laboratories
  • The approved kappa agonists act at its receptor, so a reader looking for a medicine will find it under dynorphin A rather than here

Beyond the body’s own use

  • Nothing containing it is in trials, and no analogue of it has been given to a person
  • Telling it from beta-neoendorphin takes chromatography, or an antiserum raised against the single extra lysine at its end: the two differ by that one residue, which is why most studies report them together 2
  • What is unknown is whether the front and back halves of prodynorphin are ever released separately. Nothing is known to switch one cut on and the other off, so the neoendorphins and the dynorphins are usually treated as one output 3

Sources

  1. Kangawa et al., Alpha-neo-endorphin, a big Leu-enkephalin with potent opiate activity, Biochemical and Biophysical Research Communications 1979
  2. Minamino et al., Beta-neo-endorphin, purification and the complete amino acid sequence, Biochemical and Biophysical Research Communications 1981
  3. Sanchez-Blazquez & Garzon, Leu-enkephalin-containing peptides from a common precursor in bioassays, European Journal of Pharmacology 1984

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.